Case Study: Roche diversifies clinical trials with CACI's demographic and health data modelling

Roche scales clinical trial diversity across 5 European markets with CACI Limited

Roche, an international pharmaceutical and diagnostics company, faced challenges in diversifying its clinical trial populations across Europe, which historically were predominantly Caucasian and from more affluent backgrounds. Evolving regulations and a lack of available data were significant hurdles. To address this, Roche's insights and analytics team worked with vendor CACI Limited.

CACI developed bespoke models for key variables like ethnicity and deprivation by combining demographic and survey data on a country-by-country basis within its InSite analytical tool. This solution provided Roche with data-driven decision-making capabilities, allowing them to identify optimal locations for recruiting diverse trial patients. The vendor CACI successfully scaled its model across multiple countries, augmenting Roche's diversity strategy and enabling quick, innovative data generation that was previously unavailable.

Roche